101 related articles for article (PubMed ID: 14523330)
1. Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders.
Bull G; Shattock P; Whiteley P; Anderson R; Groundwater PW; Lough JW; Lees G
Med Sci Monit; 2003 Oct; 9(10):CR422-5. PubMed ID: 14523330
[TBL] [Abstract][Full Text] [Related]
2. Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?
Wang L; Angley MT; Gerber JP; Young RL; Abarno DV; McKinnon RA; Sorich MJ
Biomarkers; 2009 Dec; 14(8):596-603. PubMed ID: 19697973
[TBL] [Abstract][Full Text] [Related]
3. Is the presence of urinary indolyl-3-acryloylglycine associated with autism spectrum disorder?
Wright B; Brzozowski AM; Calvert E; Farnworth H; Goodall DM; Holbrook I; Imrie G; Jordan J; Kelly A; Miles J; Smith R; Town J
Dev Med Child Neurol; 2005 Mar; 47(3):190-2. PubMed ID: 15739724
[TBL] [Abstract][Full Text] [Related]
4. Modeling clinical outcome of children with autistic spectrum disorders.
Coplan J; Jawad AF
Pediatrics; 2005 Jul; 116(1):117-22. PubMed ID: 15995041
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome?
Wang L; Angley MT; Sorich MJ; Young RL; McKinnon RA; Gerber JP
Autism Res; 2010 Oct; 3(5):268-72. PubMed ID: 20589913
[TBL] [Abstract][Full Text] [Related]
6. Identification of indolyl-3-acryloylglycine in the urine of people with autism.
Anderson RJ; Bendell DJ; Garnett I; Groundwater PW; Lough WJ; Mills MJ; Savery D; Shattock PE
J Pharm Pharmacol; 2002 Feb; 54(2):295-8. PubMed ID: 11858215
[TBL] [Abstract][Full Text] [Related]
7. Can urinary indolylacroylglycine levels be used to determine whether children with autism will benefit from dietary intervention?
Wilson J; Wright B; Jost S; Smith R; Pearce H; Richardson S
Pediatr Res; 2017 Apr; 81(4):672-679. PubMed ID: 27879968
[TBL] [Abstract][Full Text] [Related]
8. Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.
Emanuele E; Colombo R; Martinelli V; Brondino N; Marini M; Boso M; Barale F; Politi P
Neuro Endocrinol Lett; 2010; 31(1):117-21. PubMed ID: 20150873
[TBL] [Abstract][Full Text] [Related]
9. Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders.
Endo T; Shioiri T; Kitamura H; Kimura T; Endo S; Masuzawa N; Someya T
Biol Psychiatry; 2007 Nov; 62(9):1030-7. PubMed ID: 17631869
[TBL] [Abstract][Full Text] [Related]
10. [Urine peptide patterns in children with milder types of autism].
Sponheim E; Myhre AM; Reichelt KL; Aalen OO
Tidsskr Nor Laegeforen; 2006 May; 126(11):1475-7. PubMed ID: 16732341
[TBL] [Abstract][Full Text] [Related]
11. MRI-based morphometry in children with multiple complex developmental disorder, a phenotypically defined subtype of pervasive developmental disorder not otherwise specified.
Lahuis BE; Durston S; Nederveen H; Zeegers M; Palmen SJ; Van Engeland H
Psychol Med; 2008 Sep; 38(9):1361-7. PubMed ID: 17825125
[TBL] [Abstract][Full Text] [Related]
12. Urine interleukin-8 as a marker of vesicoureteral reflux in infants.
Galanakis E; Bitsori M; Dimitriou H; Giannakopoulou C; Karkavitsas NS; Kalmanti M
Pediatrics; 2006 May; 117(5):e863-7. PubMed ID: 16585276
[TBL] [Abstract][Full Text] [Related]
13. Development in infants with autism spectrum disorders: a prospective study.
Landa R; Garrett-Mayer E
J Child Psychol Psychiatry; 2006 Jun; 47(6):629-38. PubMed ID: 16712640
[TBL] [Abstract][Full Text] [Related]
14. Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders.
Landa RJ; Holman KC; Garrett-Mayer E
Arch Gen Psychiatry; 2007 Jul; 64(7):853-64. PubMed ID: 17606819
[TBL] [Abstract][Full Text] [Related]
15. Variability in outcome for children with an ASD diagnosis at age 2.
Turner LM; Stone WL
J Child Psychol Psychiatry; 2007 Aug; 48(8):793-802. PubMed ID: 17683451
[TBL] [Abstract][Full Text] [Related]
16. Screening strategies for autism spectrum disorders in pediatric primary care.
Pinto-Martin JA; Young LM; Mandell DS; Poghosyan L; Giarelli E; Levy SE
J Dev Behav Pediatr; 2008 Oct; 29(5):345-50. PubMed ID: 18852608
[TBL] [Abstract][Full Text] [Related]
17. Advancing paternal age and autism.
Reichenberg A; Gross R; Weiser M; Bresnahan M; Silverman J; Harlap S; Rabinowitz J; Shulman C; Malaspina D; Lubin G; Knobler HY; Davidson M; Susser E
Arch Gen Psychiatry; 2006 Sep; 63(9):1026-32. PubMed ID: 16953005
[TBL] [Abstract][Full Text] [Related]
18. Measurement of urine indolylacroylglycine is not useful in the diagnosis or dietary management of autism.
Dalton NR; Chandler S; Turner C; Charman T; Pickles A; Simonoff E; Baird G
Autism Res; 2017 Mar; 10(3):408-413. PubMed ID: 27569540
[TBL] [Abstract][Full Text] [Related]
19. Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening.
Arias A; Corbella M; Fons C; Sempere A; García-Villoria J; Ormazabal A; Poo P; Pineda M; Vilaseca MA; Campistol J; Briones P; Pàmpols T; Salomons GS; Ribes A; Artuch R
Clin Biochem; 2007 Nov; 40(16-17):1328-31. PubMed ID: 17825809
[TBL] [Abstract][Full Text] [Related]
20. Absence of urinary opioid peptides in children with autism.
Cass H; Gringras P; March J; McKendrick I; O'Hare AE; Owen L; Pollin C
Arch Dis Child; 2008 Sep; 93(9):745-50. PubMed ID: 18337276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
